1
|
Kurokawa K, Shukuya T, Greenstein RA, Kaplan BG, Wakelee H, Ross JS, Miura K, Furuta K, Kato S, Suh J, Sivakumar S, Sokol ES, Carbone DP, Takahashi K. Genomic characterization of thymic epithelial tumors in a real-world dataset. ESMO Open 2023; 8:101627. [PMID: 37703595 PMCID: PMC10594028 DOI: 10.1016/j.esmoop.2023.101627] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 05/25/2023] [Accepted: 08/02/2023] [Indexed: 09/15/2023] Open
Abstract
BACKGROUND Thymic epithelial tumors (TETs) are rare neoplasms arising in the mediastinum, including thymic carcinomas and thymomas. Due to their rarity, little is known about the genomic profiles of TETs. Herein, we investigated the genomic characteristics of TETs evaluated in a large comprehensive genomic profiling database in a real-world setting. METHODS We included data from two different cohorts: Foundation Medicine Inc. (FMI) in the United States and the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) in Japan. Samples profiled were examined for all classes of alterations in 253 genes targeted across all assays. Tumor mutational burden (TMB) and microsatellite instability (MSI) were also evaluated. RESULTS A total of 794 patients were collected in our study, including 722 cases from FMI and 72 cases from C-CAT. In the FMI data, CDKN2A (39.9%), TP53 (30.2%) and CDKN2B (24.6%) were frequently altered in thymic carcinoma, versus TP53 (7.8%), DNMT3A (6.8%), and CDKN2A (5.8%) in thymoma. TMB-high (≥10 mutations/Mb) and MSI were present in 7.0% and 2.3% of thymic carcinomas, and 1.6% and 0.3% of thymomas, respectively. Within C-CAT data, CDKN2A (38.5%), TP53 (36.5%) and CDKN2B (30.8%) were also frequently altered in thymic carcinoma, while alterations of TSC1, SETD2 and LTK (20.0% each) were found in thymoma. CONCLUSIONS To the best of our knowledge, this is the largest cohort in which genomic alterations, TMB and MSI status of TETs were investigated. Potential targets for treatment previously unbeknownst in TETs are identified in this study, entailing newfound opportunities to advance therapeutic development.
Collapse
Affiliation(s)
- K Kurokawa
- Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
| | - T Shukuya
- Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
| | | | - B G Kaplan
- Foundation Medicine, Inc., Cambridge, USA
| | - H Wakelee
- Department of Medicine, Division of Oncology, Stanford University, Stanford, USA
| | - J S Ross
- Foundation Medicine, Inc., Cambridge, USA; Departments of Pathology and Urology, Upstate Medical University, Syracuse, USA
| | - K Miura
- Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
| | - K Furuta
- Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
| | - S Kato
- Department of Medical Oncology, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
| | - J Suh
- Genentech, South San Francisco, USA
| | | | - E S Sokol
- Foundation Medicine, Inc., Cambridge, USA
| | - D P Carbone
- Comprehensive Cancer Center, Division of Medical Oncology, The Ohio State University, Columbus, USA
| | - K Takahashi
- Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
| |
Collapse
|
2
|
Shimotsuma Y, Kinouchi K, Yanoshita R, Fujiwara M, Mizuochi N, Uemoto M, Shimizu M, Miura K. Formation of NV centers in diamond by a femtosecond laser single pulse. Opt Express 2023; 31:1594-1603. [PMID: 36785191 DOI: 10.1364/oe.475917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 11/20/2022] [Indexed: 06/18/2023]
Abstract
The NV centers in a diamond were successfully created by the femtosecond laser single pulse. We also investigated the effect on the diamond lattice induced by the different laser pulse widths from both experimental and theoretical perspectives. Interestingly, in spite of the high thermal conductivity of a diamond, we found that there is a suitable pulse repetition rate of several tens kHz for the formation of NV center ensembles by the femtosecond laser pulse irradiation.
Collapse
|
3
|
Kaneda H, Hazama D, Kodama H, Miyazaki A, Azuma K, Kawashima Y, Sato Y, Ito K, Shiraishi Y, Miura K, Takahama T, Oizumi S, Namba Y, Ikeda S, Miura S, Tachihara M. 333P Efficacy and safety of immune checkpoint inhibitors alone or combined with chemotherapy in pulmonary sarcomatoid carcinoma. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
4
|
Matsuoka S, Eguchi T, Iwaya M, Ide S, Mishima S, Takeda T, Miura K, Hamanaka K, Shimizu K. P2.12-02 Immune-Cell Distribution Between Tumor Edge and Center Affects Lung Cancer Aggressiveness - Multiplex Immunofluorescence. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Eguchi T, Matsuoka S, Iwaya M, Uehara T, Kobayashi S, Ide S, Mishima S, Takeda T, Miura K, Hamanaka K, Shimizu K. MA03.07 Accurate Intraoperative Diagnosis of Spread Through Air Spaces (STAS) Using a Cryo Embedding Medium Inflation Method. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Matsuoka H, Narita Y, Misumi T, Sakamoto Y, Kawakami T, Tanioka H, Matsushima T, Miwa H, Shoji H, Ishiguro A, Fushida S, Miura K, Yamada T, Shinozaki K, Mizukami T, Moriwaki T, Mitani S, Nakamura M, Muro K, Nishina T. P-61 Impacts of salvage chemotherapy after nivolumab therapy (NIVO): A REVIVE substudy. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
7
|
Wada S, Namiki T, Miura K, Miyazaki Y. Propylthiouracil-induced vasculitis presenting as purpuric plaques on cheeks. Clin Exp Dermatol 2021; 47:581-582. [PMID: 34637160 DOI: 10.1111/ced.14973] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 09/26/2021] [Accepted: 10/07/2021] [Indexed: 12/01/2022]
Affiliation(s)
- S Wada
- Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - T Namiki
- Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - K Miura
- Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - Y Miyazaki
- Department of Dermatology, National Hospital Organization Disaster Medical Center, Tokyo, Japan
| |
Collapse
|
8
|
Takahashi N, Izawa N, Nishio K, Masuishi T, Shoji H, Yamamoto Y, Matsumoto T, Sugiyama K, Kajiwara T, Kawakami K, Aomatsu N, Kawakami H, Esaki T, Narita Y, Hara H, Horie Y, Boku N, Miura K, Moriwaki T, Shimokawa M, Nakajima T, Muro K. O-6 Gene alterations in ctDNA related to the resistance mechanism of anti-EGFR antibodies and clinical efficacy outcomes of anti-EGFR antibody rechallenge plus trifluridine/tipiracil in metastatic colorectal cancer patients in WJOG8916G trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
9
|
Affiliation(s)
- S Wada
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - T Namiki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - S Tokoro
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - K Miura
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - H Yokozeki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| |
Collapse
|
10
|
Imai Y, Sakurai M, Nakagawa H, Hirata A, Murakami Y, Kiyohara Y, Ninomiya T, Ishikawa S, Saitoh S, Irie F, Sairenchi T, Kiyama M, Miura K, Ueshima H, Okamura T. Impact of Proteinuria and Low eGFR on Lifetime Risk of Cardiovascular Disease Death: A Pooled Analysis of Data From the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Study. Eur J Prev Cardiol 2021. [DOI: 10.1093/eurjpc/zwab061.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): H20–Junkankitou [Seishuu]–Ippan–013; H23–Junkankitou [Seishuu]–Ippan–005; H26-Junkankitou [Seisaku]-Ippan-001; H29–Junkankitou–Ippan–003 and 20FA1002
OnBehalf
EPOCH-JAPAN
Introduction
Absolute risk of Lifetime risk (LTR) is useful estimate for risk communication compared with short term risk or relative risk especially for young people. Proteinuria is leading cause of end-stage kidney disease (ESKD) and independent risk factor for cardiovascular disease (CVD). Although nonproteinuric renal disease is global burden of ESKD, it has been poorly focused. To date, there have been no reports of impact of proteinuria and low eGFR on LTR with the outcome of CVD death in Asian population.
Purpose
We aimed to estimate LTR of CVD death stratified by the status of proteinuria and low eGFR.
Methods
We used modified Kaplan-Meier approach to estimate the remaining lifetime risk of cardiovascular death based on EPOCH-JAPAN(Evidence for Cardiovascular Prevention From Observational Cohorts in Japan) database. LTR was estimated at each index age starting from 40 years for those with proteinuria and without proteinuria stratified by low eGFR, which is defined as eGFR <60 ml/min/1.73 m². Participants were classified into three groups, which were those with proteinuria (Proteinuria (+)), those without proteinuria with low eGFR (Proteinuria (-)/Low eGFR (+)), those without proteinuria without low eGFR (Proteinuria (-)/Low eGFR (-)).
Results
A total of 47,292 participants from 9 cohorts was included in the analysis. Mean follow-up period was 14.6 years with 690,463 person years and total CVD death was 1,075 in men and 1,193 in women. The LTRs at the index age of 40 years were as follows: 17.7% (95% confidence interval: 15.4 – 19.0%) in Proteinuria (-)/Low eGFR (-) group, 26.2% (20.2 – 31.1%) in Proteinuria (-)/low eGFR (+) group, 24.5% (15.1 – 29.3%) in Proteinuria (+) group for men; 15.3%(13.7 – 16.5%), 29.9%(14.7 – 46.8%) , 28.3%(19.4 – 34.7%) for women.
Conclusions
We observed that those without proteinuria with low eGFR have equivalently high LTR with those with proteinuria. These results indicate that even in the absence of proteinuria, low eGFR has high impact on LTR. Lifestyle modification from young age is necessary to prevent from renal dysfunction.
Collapse
Affiliation(s)
- Y Imai
- Keio University School of Medicine, Tokyo, Japan
| | - M Sakurai
- Kanazawa Medical University, Department of Epidemiology and Public Health, Kanazawa, Japan
| | - H Nakagawa
- Kanazawa Medical University, Department of Epidemiology and Public Health, Kanazawa, Japan
| | - A Hirata
- Keio University School of Medicine, Tokyo, Japan
| | - Y Murakami
- Toho University, Department of Medical Statistics, Tokyo, Japan
| | - Y Kiyohara
- Hisayama Research Institute for Lifestyle Disease, Fukuoka, Japan
| | - T Ninomiya
- Kyushu University Graduate School of Medical Sciences, Department of Epidemiology and Public Health, Fukuoka, Japan
| | - S Ishikawa
- Jichi Medical University, Medical Education Center, Tochigi, Japan
| | - S Saitoh
- Sapporo Medical University School of Health Sciences, Department of Nursing, Hokkaido, Japan
| | - F Irie
- Ibaraki Prefectural Office, Department of Health and Welfare, Ibaraki, Japan
| | - T Sairenchi
- Dokkyo Medical University School of Medicine, Department of Public Health, Tochigi, Japan
| | - M Kiyama
- Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
| | - K Miura
- Shiga University of Medical Science, Department of Public Health, Shiga, Japan
| | - H Ueshima
- Shiga University of Medical Science, Department of Public Health, Shiga, Japan
| | - T Okamura
- Keio University School of Medicine, Tokyo, Japan
| |
Collapse
|
11
|
Borsanyi S, Fodor Z, Guenther JN, Hoelbling C, Katz SD, Lellouch L, Lippert T, Miura K, Parato L, Szabo KK, Stokes F, Toth BC, Torok C, Varnhorst L. Leading hadronic contribution to the muon magnetic moment from lattice QCD. Nature 2021; 593:51-55. [PMID: 33828303 DOI: 10.1038/s41586-021-03418-1] [Citation(s) in RCA: 57] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2020] [Accepted: 03/04/2021] [Indexed: 02/02/2023]
Abstract
The standard model of particle physics describes the vast majority of experiments and observations involving elementary particles. Any deviation from its predictions would be a sign of new, fundamental physics. One long-standing discrepancy concerns the anomalous magnetic moment of the muon, a measure of the magnetic field surrounding that particle. Standard-model predictions1 exhibit disagreement with measurements2 that is tightly scattered around 3.7 standard deviations. Today, theoretical and measurement errors are comparable; however, ongoing and planned experiments aim to reduce the measurement error by a factor of four. Theoretically, the dominant source of error is the leading-order hadronic vacuum polarization (LO-HVP) contribution. For the upcoming measurements, it is essential to evaluate the prediction for this contribution with independent methods and to reduce its uncertainties. The most precise, model-independent determinations so far rely on dispersive techniques, combined with measurements of the cross-section of electron-positron annihilation into hadrons3-6. To eliminate our reliance on these experiments, here we use ab initio quantum chromodynamics (QCD) and quantum electrodynamics simulations to compute the LO-HVP contribution. We reach sufficient precision to discriminate between the measurement of the anomalous magnetic moment of the muon and the predictions of dispersive methods. Our result favours the experimentally measured value over those obtained using the dispersion relation. Moreover, the methods used and developed in this work will enable further increased precision as more powerful computers become available.
Collapse
Affiliation(s)
- Sz Borsanyi
- Department of Physics, University of Wuppertal, Wuppertal, Germany
| | - Z Fodor
- Department of Physics, University of Wuppertal, Wuppertal, Germany. .,Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany. .,Department of Physics, Pennsylvania State University, University Park, PA, USA. .,Institute for Theoretical Physics, Eötvös University, Budapest, Hungary. .,Department of Physics, University of California, San Diego, La Jolla, CA, USA.
| | - J N Guenther
- Department of Physics, University of Regensburg, Regensburg, Germany.,Aix Marseille Université, Université de Toulon, CNRS, CPT, IPhU, Marseille, France
| | - C Hoelbling
- Department of Physics, University of Wuppertal, Wuppertal, Germany
| | - S D Katz
- Institute for Theoretical Physics, Eötvös University, Budapest, Hungary
| | - L Lellouch
- Aix Marseille Université, Université de Toulon, CNRS, CPT, IPhU, Marseille, France
| | - T Lippert
- Department of Physics, University of Wuppertal, Wuppertal, Germany.,Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany
| | - K Miura
- Aix Marseille Université, Université de Toulon, CNRS, CPT, IPhU, Marseille, France.,Helmholtz Institute Mainz, Mainz, Germany.,Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, Nagoya University, Nagoya, Japan
| | - L Parato
- Aix Marseille Université, Université de Toulon, CNRS, CPT, IPhU, Marseille, France
| | - K K Szabo
- Department of Physics, University of Wuppertal, Wuppertal, Germany.,Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany
| | - F Stokes
- Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany
| | - B C Toth
- Department of Physics, University of Wuppertal, Wuppertal, Germany
| | - Cs Torok
- Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany
| | - L Varnhorst
- Department of Physics, University of Wuppertal, Wuppertal, Germany.,Aix Marseille Université, Université de Toulon, CNRS, CPT, IPhU, Marseille, France
| |
Collapse
|
12
|
Kumagawa M, Matsumoto N, Miura K, Ogawa M, Takahashi H, Hatta Y, Kondo R, Koizumi N, Takei M, Moriyama M. Correlation between alterations in blood flow of malignant lymphomas after induction chemotherapies and clinical outcomes: a pilot study utilising contrast-enhanced ultrasonography for early interim evaluation of lymphoma treatment. Clin Radiol 2021; 76:550.e9-550.e17. [PMID: 33691950 DOI: 10.1016/j.crad.2021.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2019] [Accepted: 02/04/2021] [Indexed: 02/07/2023]
Abstract
AIM To clarify the utility of contrast-enhanced ultrasonography (CEUS) for interim evaluation of response to chemotherapy in lymphoma treatment. MATERIALS AND METHODS CEUS was performed both before (day 0) and after the treatment (7 and/or 14 days), and a time-intensity curve was obtained. The patients were divided into two groups (complete remission [CR] group and non-CR group) according to the results of conventional response evaluation, and peak enhancement (PE), time to peak enhancement, perfusion index (PI), the total area under the curve during wash-in (AUC-in), and the total AUC were compared between the groups. RESULTS Among 27 patients with various types of lymphoma, the median change ratio of PE and PI at day 7 evaluation were significantly different between the CR group and the non-CR group (0.81 versus 1.39, p=0.017 for PE and 0.92 versus 2.09, p=0.010 for PI). The change ratio of PE < 1.09 (specificity: 86%; sensitivity, 88%) and PI < 1.65 (specificity: 86%; sensitivity: 94%) distinguished CR from non-CR. Patients who achieved a PE change ratio <1.09 or a PI change ratio <1.65 had significantly better estimated progression-free survival (p<0.001). CONCLUSION The present study demonstrated that changes in tumour perfusion parameters evaluated with CEUS at 1 week after the treatment initiation were significantly different between lymphoma patients in CR group and non-CR group. Alterations in perfusion parameters evaluated via CEUS could impact the prognosis of lymphoma patients.
Collapse
Affiliation(s)
- M Kumagawa
- Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan
| | - N Matsumoto
- Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan.
| | - K Miura
- Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan.
| | - M Ogawa
- Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan
| | - H Takahashi
- Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan
| | - Y Hatta
- Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan
| | - R Kondo
- Department of Mechanical Engineering and Intelligent Systems, Graduate School of Informatics and Engineering, The University of Electro-Communications, 1-5-1, Chofugaoka, Chofu-shi, Tokyo, Japan
| | - N Koizumi
- Department of Mechanical Engineering and Intelligent Systems, Graduate School of Informatics and Engineering, The University of Electro-Communications, 1-5-1, Chofugaoka, Chofu-shi, Tokyo, Japan
| | - M Takei
- Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan
| | - M Moriyama
- Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan
| |
Collapse
|
13
|
Saito R, Tsubata Y, Nakamura A, Yoshioka H, Morita M, Honda R, Kanaji N, Watanabe M, Jingu D, Nakagawa T, Nakazawa K, Mouri A, Takeuchi S, Furuya N, Akazawa Y, Miura K, Ichihara E, Kobayashi K, Morita S, Isobe T. P76.79 Osimertinib in Poor PS Patients with T790M-Positive Advanced NSCLC after Progression of EGFR TKI Treatments (NEJ032B). J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Shima Y, Miura K, Tada T, Tanaka H, Fuku Y, Kadota K. Prevalence and impact of ischemic risk on long-term bleeding and ischemic event for high bleeding risk patients. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1336] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Impact of ischemic risk (IR) on long term outcomes in patients at high bleeding risk (HBR) after everolimus-eluting stent (EES) implantation remains unclear.
Purpose
We aimed to evaluate long term bleeding and ischemic events in patient with HBR or IR after EES implantation.
Methods
The study population comprised 1219 patients treated with EES without in-hospital events between 2010 and 2011. The follow-up period was 2996±433 days. HBR was defined as Academic research consortium. IR defined as high-risk features of stent-driven recurrent ischemic events in Europe society of cardiology guidelines in 2019: prior stent thrombosis on adequate antiplatelet therapy, diffuse multivessel disease especially in diabetic patients, creatinine clearance <60 ml/min, at least three stents implanted, bifurcation two stents implanted, total stent length >60 mm, and treatment of a chronic total occlusion. Major bleeding (MB) was defined as defined as the occurrence of a Bleeding Academic Research Consortium (BARC) type 3 or 5 bleeding event. Primary ischemic events included myocardial infarction, definite stent thrombosis, and cardiac death. The Kaplan-Meier method was used for time-to-event analyses.
Results
Of the 1219 patients, 317 (26.0%) patients had no risk, 114 (9.4%) patients had only HBR, 288 (23.6%) patients had only IR, and 500 (41.0%) patients had both risks. The 81.4% of HBR patients had IR. The figure of Kaplan-Meier showed MB and CE for 7–8 years. Both risk groups had higher bleeding risk and Ischemic events (log rank p=0.0039, 0.0001).
Conclusion
HBR patients with EES had a high incidence of IR. Patients who had both HBR and IR are especially at risk for both ischemic events and bleeding compared to those who had no or only one risk.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- Y Shima
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Miura
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Tada
- Kurashiki Central Hospital, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Kurashiki, Japan
| |
Collapse
|
15
|
Masumoto A, Ohya M, Murai R, Miura K, Shimada T, Amano H, Kubo S, Tada T, Tanaka H, Fuku Y, Kadota K. Early restenosis and late catch-up phenomenon after newer biodegradable- and durable-polymer drug-eluting stent implantations. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
It is yet to be known whether mechanisms underlying restenosis in newer-generation durable-polymer (DP) and biodegradable-polymer (BP) drug-eluting stents (DES) are different.
Purpose
This study aims to assess the incidences and predictors of early restenosis and late catch-up phenomenon after newer-generation durable-polymer (DP) and biodegradable-polymer (BP) DES.
Methods
Between 2010 and 2017, 13858 lesions in 6350 patients were treated with DES (4393 BP-DES, 9465 DP-DES). The early-term (within 1 year) and late-term (from 1 to 2 years) follow-up angiographies were scheduled. Late catch-up phenomenon was defined as in-stent restenosis (ISR) in lesions that evaded ISR within 1 year after stent implantation. ISR was defined as angiographic restenosis of more than 50%.
Results
The mean patient age was 71 years, and 76.7% were male. Early-term angiographies were performed in 10955 lesions (79.0%). Of those without early-term ISR, late-term angiographies were performed in 7771 lesions (56.1%). The incidences of mid-term restenosis and late catch-up phenomenon were 6.6% and 3.9%, respectively.
In the multivariate regression analyses, history of diabetes, hemodialysis and previous PCI were independent predictors of both early restenosis and late catch-up phenomenon. Also, some lesion characteristics such as chronic total occlusion, right coronary artery ostial lesion, small vessel (defined as reference diameter <2.5mm), long lesion (defined as lesion length >30mm) and treatment of ISR lesion were independent predictors of both early restenosis and late catch-up phenomenon.
Bifurcation lesion and heavily calcified lesion treated with rotablator were independent risk of early restenosis. Bypass graft lesion was an independent predictor of late catch-up phenomenon.
Early restenosis was observed less frequently in DP-DES than in BP-DES (6.3% versus 7.4%, P=0.012). On the contrary, late catch-up phenomenon was observed more frequently in DP-DES than in BP-DES (4.3% versus 2.9%, P=0.026).
Conclusions
Some lesion characteristics were independent predictors of early restenosis and late catch-up phenomenon after newer-generation DES implantation. The deployment of BP-DES resulted in more early restenosis and less late catch-up phenomenon compared to that of DP-DES.
Early Restenosis and Late Catch-Up
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - M Ohya
- Kurashiki Central Hospital, Kobe, Japan
| | - R Murai
- Kurashiki Central Hospital, Kobe, Japan
| | - K Miura
- Kurashiki Central Hospital, Kobe, Japan
| | - T Shimada
- Kurashiki Central Hospital, Kobe, Japan
| | - H Amano
- Kurashiki Central Hospital, Kobe, Japan
| | - S Kubo
- Kurashiki Central Hospital, Kobe, Japan
| | - T Tada
- Kurashiki Central Hospital, Kobe, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Kobe, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Kobe, Japan
| | - K Kadota
- Kurashiki Central Hospital, Kobe, Japan
| |
Collapse
|
16
|
Hata R, Shimada T, Shima Y, Okabe K, Ohya M, Miura K, Murai R, Amano H, Kubo S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. Clinical features and prognosis of acute myocardial infarction due to coronary artery embolism. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Coronary artery embolism (CE) is one of the important causes of acute coronary syndrome (ACS). The feature of CE is that angiographic evidence of coronary artery embolism and thrombosis without atherosclerotic components. However, the prevalence of CE remains unknown because of the diffifulty to diagnose in the acute settings. A recent retrospective analysis suggested that up to 3% of ACS cases may result from CE.
Purpose
The aim of this study was to elucidate the prevalence, clinical features and long-term outcomes including all-cause and cardiac death.
Methods
We analysed the consecutive 2695 patients with first AMI performed coronary intervention between January 2004 and July 2017. CE was diagnosed by clinical histories and angiographic findings. We retrospectively evaluated the clinical and lesion characteristics and outcomes including all-cause and cardiac death.
Results
The prevalence of CE was 2.0% (n=55; CE group and n=2640; non-CE group), including 8 (15%) patients with multivessel CE. The CE group had higher average age (70.8±14.9 vs. 68.4±12.6, p<0.01), prevalence of female (54% vs. 27%, p<0.01), lower prevalence of smoking (34% vs. 62%, p<0.01). The common causes with CE were atrial fibrillation (47%), and malignant tumor (9%), and cardiomyopathy (5%), and patent foramen ovale (4%). Only 20% of patients with CE were treated with anti-coagulant therapy. The rate of distal infarction site (defined as #4, #8, #14–15) was significantly higher in CE group than non-CE group (54.0% vs. 4.9%, p<0.01). During median follow-up of 53.6 [32.6–77.3] months, CE and thromboembolism recurred in 5 patients (CE: 1 patient, stroke 4 patients). The 4-year incidence of all-cause death was significantly higher in the CE group, but cardiac death was not significantly different between the groups (28.8% vs. 14.8%, p=0.03; 12.8% vs. 5.1%, p=0.11).
Conclusion
Compared with non-CE group, the prevalence of distal infarction site was significantly higher in the CE group, and the incidence of cardiac death is not significantly different.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- R Hata
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - T Shimada
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - Y Shima
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - K Okabe
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - M Ohya
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - K Miura
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - R Murai
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - H Amano
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - S Kubo
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - T Tada
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - T Goto
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Cardiology, Kurashiki, Japan
| |
Collapse
|
17
|
Miura K, Shimada T, Ohya M, Murai R, Amano H, Kubo S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. Risk stratification based on academic research consortium high bleeding risk criteria for long-term bleeding event after everolimus-eluting stent implantation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Recently, the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria has been suggested as the standard definition of HBR.
Purpose
We aimed to investigate the risk stratification based on ARC-HBR Criteria for long-term bleeding event after everolimus-eluting stent implantation
Methods
The study population comprised 1193 patients treated with EES without in-hospital event between 2010 and 2011. Individual ARC-HBR criteria was retrospectively assessed. Major bleeding were defined as the occurrence of a Bleeding Academic Research Consortium type 3 or 5 bleeding event. The mean follow-up period was 2996±433 days.
Results
There were 656 patients (55.0%) in HBR-groups. Cumulative incidence of major bleeding was significantly higher in HBR-group (8.1% vs 3.4% at 4 year, and 16.2% vs 5.7% at 8 year, P<0.001). Cumulative rate of major bleeding tend to be higher as the number of ARC-HBR criteria increased (≥2 Majors: 24.3%, 1 Major: 17.0%, ≥2 Minors:11.7%, and Non-HBR: 5.7%, P<0.001).
Conclusion
ARC-HBR criteria successfully stratified the long-term bleeding risk after drug-eluting stent implantation in real-world practice.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- K Miura
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Shimada
- Kurashiki Central Hospital, Kurashiki, Japan
| | - M Ohya
- Kurashiki Central Hospital, Kurashiki, Japan
| | - R Murai
- Kurashiki Central Hospital, Kurashiki, Japan
| | - H Amano
- Kurashiki Central Hospital, Kurashiki, Japan
| | - S Kubo
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Tada
- Kurashiki Central Hospital, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Goto
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Kurashiki, Japan
| |
Collapse
|
18
|
Way M, Marquart L, Chambers DC, Hopkins P, Miura K, Jiyad Z, Plasmeijer EI, Ferguson LE, Davis M, Whiteman DC, Soyer HP, O'Rourke P, Green AC. Skin cancer multiplicity in lung transplant recipients: a prospective population-based study. Br J Dermatol 2020; 183:503-508. [PMID: 31853948 DOI: 10.1111/bjd.18812] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/16/2019] [Indexed: 12/30/2022]
Abstract
BACKGROUND Lung transplant recipients are at high risk of skin cancer, but precise annual incidence rates of treated skin cancers per patient are unknown. OBJECTIVES To perform a prospective assessment of the total burden of histologically confirmed squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) and associated factors in lung transplant recipients. METHODS A population-based cohort of 125 Queensland lung transplant recipients aged 18 years and over, recruited between 2013 and 2015, were followed to the end of 2016. All underwent dermatological skin examinations at baseline and annually thereafter and patients self-reported all interim treated skin cancers, which were verified against pathology databases. Standard skin cancer risk factors were obtained via questionnaire, and details of medications were acquired from hospital records. RESULTS During a median follow-up time of 1·7 years, 29 (23%) and 30 (24%) lung transplant recipients with a median duration of immunosuppression of 3·3 years developed SCC and BCC, respectively. The general population age-standardized incidence rates of SCC and BCC were 201 and 171 per 1000 person-years, respectively (based on first primary SCC or BCC during follow-up); however, on accounting for multiple primary tumours, corresponding incidence rates were 447 and 281 per 1000 person-years. Risk of multiple SCCs increased around sixfold in those aged ≥ 60 years and in those with previous skin cancer, and increased around threefold in those treated with the antifungal medication voriconazole. Multiple BCC risk rose threefold from age 60 years and tenfold for patients with previous skin cancer. CONCLUSIONS Lung transplant recipients have very high incidence of multiple primary skin cancers. Close surveillance and assiduous prevention measures are essential. Linked Comment: Proby and Harwood. Br J Dermatol 2020; 183:416-417.
Collapse
Affiliation(s)
- M Way
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.,Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - L Marquart
- Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - D C Chambers
- Queensland Lung Transplant Service, Prince Charles Hospital; and School of Medicine, University of Queensland, Brisbane, Australia
| | - P Hopkins
- Queensland Lung Transplant Service, Prince Charles Hospital; and School of Medicine, University of Queensland, Brisbane, Australia
| | - K Miura
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - Z Jiyad
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.,Institute of Cardiovascular and Cell Sciences (Dermatology Unit), St George's University of London, London, U.K
| | - E I Plasmeijer
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.,Department of Dermatology, Erasmus Medical Centre, Erasmus University, Rotterdam, the Netherlands
| | - L E Ferguson
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - M Davis
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - D C Whiteman
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - H P Soyer
- Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.,Dermatology Research Centre, University of Queensland, University of Queensland Diamantina Institute, Brisbane, Australia
| | - P O'Rourke
- Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - A C Green
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.,CRUK Manchester Institute and Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, U.K
| |
Collapse
|
19
|
Fujii T, Arima H, Yamamoto T, Sawayama Y, Takashima N, Kita Y, Tanaka S, Miyamatsu N, Miura K, Nozaki K. Challenges in a population-based registry of cardiovascular disease in Shiga, Japan. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz186.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Stroke and cardiovascular disease are one of the leading causes of death and disability in Japan. In order to investigate current burden, we conduct a population-based registry of cardiovascular disease in Shiga Prefecture, Japan since 2012. We will demonstrate challenges in conduct of the registry study.
Methods
In 2012, we established the Shiga Stroke Registry (SSR), a multicenter population-based registry study designed to build a complete information system for the management of stroke in Shiga Prefecture, Japan. The registry uses local monitoring, combined with remote data collection and quality control systems, to create an integrated surveillance system among a network of all acute care hospitals with neurology/neurosurgery facilities and smaller hospitals with rehabilitation facilities in the region. In 2019, study name has changed to Shiga Stroke and Heart Attack Registry (SSHR) and additional registration of coronary heart disease and aortic disease have started. Each case is reviewed and adjudicated by 2 or more specialists.
Results
In the financial year of 2018 (from April to March), a total of 4809 stroke cases were identified. From December 2018 to April 2019, a total of 515 coronary heart and aortic diseases were identified. A total 10 nurses work full-time for the registry and it takes average of 1 hour to collect information for each patient. Challenges in conduct of the cardiovascular registry involve regulatory and ethical approval, funding, associations with local hospitals, non-standardized hospital diagnosis, staff training for comprehensive data collection including pathophysiology, examination and treatment, and quality control of data collection.
Conclusions
SSHR is a population-based registry of wide range of stroke and cardiovascular disease in Shiga Prefecture, Japan. In order to keep quality of the data, we put a lot of efforts on staff training and quality control.
Key messages
Population-based registry of wide range of stroke and cardiovascular disease in Shiga, Japan. In order to keep quality of the data, we put a lot of efforts on staff training and quality control.
Collapse
Affiliation(s)
- T Fujii
- Department of Neurosurgery, Shiga University of Medical Science, Otsu, Japan
- Department of Preventive Medicine and Public Health, Faculty, Fukuoka University, Fukuoka, Japan
| | - H Arima
- Department of Preventive Medicine and Public Health, Faculty, Fukuoka University, Fukuoka, Japan
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan
| | - T Yamamoto
- Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan
| | - Y Sawayama
- Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan
| | - N Takashima
- Department of Public Health, Kinki University, Osaka-Sayama, Japan
| | - Y Kita
- Tsuruga University, Tsuruga, Japan
| | - S Tanaka
- Department of Medical Statistics, Shiga University of Medical Science, Otsu, Japan
| | - N Miyamatsu
- Department of Clinical Nursing, Shiga University of Medical Science, Otsu, Japan
| | - K Miura
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan
| | - K Nozaki
- Department of Neurosurgery, Shiga University of Medical Science, Otsu, Japan
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan
| |
Collapse
|
20
|
Okabe K, Ohya M, Matsushita K, Kuwayama A, Murai R, Miura K, Shimada T, Amano H, Kubo S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. P2693Late catch-up phenomenon and late-term target lesion revascularization of two-stenting for coronary bifurcation lesions between first and second generation drug-eluting stents. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.1010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The second generation drug-eluting stent (G2-DES) has been reported as superior to the first generation drug-eluting stent (G1-DES) in mid-term outcomes. However, the late-term outcomes between G1-DES and G2-DES in two-stenting for coronary bifurcation lesions are not well studied.
Purpose
To evaluate the late catch-up phenomenon and late-term target lesion revascularization (TLR) of two-stenting for coronary bifurcation lesions between G1-DES and G2-DES.
Methods
This study included 1133 lesions in 1089 patients undergoing drug eluting stent implantation with two stenting from 2004 to 2016. These consisted of 496 G1-DES implanted lesions and 637 G2-DES implanted lesions. Late-term follow-up angiography was performed without in-stent restenosis (ISR) and TLR at mid-term follow-up in 582 lesions (242 G1-DES lesions and 340 G2-DES lesions). ISR was defined as more than 50% restenosis. Late catch-up phenomenon was defined as ISR without ISR within 1 year following index stent implantation. Late-term TLR was defined as from 1 to 5 year TLR. Bifurcation lesions were defined as the main branch ranging from the proximal stem to the distal main branch with boundaries defined by 5 mm proximal and distal to the stent-implanted area, and the side branch ranging from the bifurcation carina to the distal side branch with boundaries defined by the carina and 5 mm distal to the stent-implanted area.
Results
The median follow-up duration was 5.1 years (the first and third quarters, 3.2 and 7.1 years). The late-catch up phenomenon rate significantly differed between the G1-DES and G2-DES groups (16.9% vs 8.4%, p=0.001). A significant difference in late catch-up between the same two groups was also observed in bifurcation lesions of the main branch (5.0% vs 0.6%, p=0.001) and side branch (10.3% vs 5.6%, p=0.033), respectively. The 5-year cumulative rates also differed between the two groups in TLR (8.2% vs 3.7% log-rank p=0.001), and late-term TLR (7.0% vs 3.6% log-rank p=0.001).
Conclusion
Two-stenting using G2-DES, compared with G1-DES, significantly reduced late-term restenosis and TLR. The restenosis rate in bifurcation area may be associated with differences between two groups in late-term outcome.
Collapse
Affiliation(s)
- K Okabe
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - M Ohya
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - K Matsushita
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - A Kuwayama
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - R Murai
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - K Miura
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - T Shimada
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - H Amano
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - S Kubo
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - S Habara
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - T Tada
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - T Goto
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Department of Cardiology, Kurashiki, Japan
| |
Collapse
|
21
|
Tada T, Miura K, Ohya M, Shimada T, Murai R, Amano H, Kubo S, Habara S, Tanaka H, Fuku Y, Kadota K. P5614The association between tissue morphology assessed with optical coherence tomography and mid and late-term results after percutaneous coronary intervention for in-stent restenosis lesions. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
It was reported that tissue morphology of in-stent restenosis (ISR) lesions assessed with optical coherence tomography (OCT) had an effect on midterm results including ISR and target lesion revascularization (TLR) rates after percutaneous coronary intervention (PCI). However, little was known about the association between tissue morphology assessed with OCT and late-term results.
Methods
We performed PCI treated with paclitaxel coated balloon (PCB) or drug-eluting stent (DES) for 452 ISR lesions (260 lesions with fibrous plaque and 192 lesions with lipid-laden plaque) using OCT between May 2008 and July 2016. Six- to eight-month (midterm) angiographic follow-up was performed on 422 of the 452 ISR lesions (follow-up rate: 93.4%). Furthermore, eighteen- to twenty-month (late-term) angiographic follow-up was performed on 337 of the 361 ISR lesions (follow-up rate: 93.4%) which were free from midterm TLR. We examined the association between tissue morphology, midterm-results and late-term results including ISR and TLR rates. Fibrous plaque was defined as homogeneous, signal-rich regions with low attenuation. Lipid-laden plaque was defined as diffuse border, signal poor regions with high attenuation.
Results
The patients were 353 men and 69 women, and the mean age was 68.8±9.6 years. PCI were performed with PCB in 285 lesions (PCB group) and DES in 137 lesions (DES group). The figure shows the angiographic midterm results of the 422 lesions and late-term results of the 337 lesions with respect to each tissue morphology and each PCI device. There was no difference in ISR and TLR rates of lesions with both fibrous and lipid-laden plaque at midterm between the two groups. ISR and TLR rates of lesions with lipid-laden plaque at late-term were significantly higher in the PCB group than in the DES group, while there was no difference in ISR and TLR rates of lesions with fibrous plaque at late-term between two groups.
Figure 1
Conclusion
Tissue morphology of ISR lesions might have an impact on outcomes after PCI. Morphological assessment of ISR tissue using OCT might suggest favorable types of PCI for ISR lesions.
Collapse
Affiliation(s)
- T Tada
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - K Miura
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - M Ohya
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - T Shimada
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - R Murai
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - H Amano
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - S Kubo
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - S Habara
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| |
Collapse
|
22
|
Takahashi H, Kawakita D, Fushimi C, Nagao T, Hirai H, Saigusa N, Masubuchi T, Matsuki T, Okada T, Baba D, Miura K, Saotome T, Tada Y. Trastuzumab plus docetaxel in patients with advanced HER2-positive salivary duct carcinoma: Exploratory biomarker analyses. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz252.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
23
|
Fushimi C, Kawakita D, Takahashi H, Nagao T, Hirai H, Saigusa N, Masubuchi T, Matsuki T, Okada T, Baba D, Miura K, Saotome T, Tada Y. Combined androgen blockade in patients with advanced androgen receptor-positive salivary gland carcinoma: Exploratory biomarker analyses. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz252.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Vu T, Fujiyoshi A, Hisamatsu T, Kadota A, Zaid M, Segawa H, Kondo K, Asai T, Miura K, Ueshima H. P4660Lipoprotein particle profiles compared with standard lipids in the association with sub-clinical aortic valve calcification in apparently healthy Japanese men. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Calcific aortic valve disease (CAVD) is one of the most common heart diseases worldwide, and its prevalence has increased in developed countries along with aging populations. Subclinical CAVD is characterized by aortic valve calcification (AVC) that may lead to aortic stenosis. AVC shares the same risk factors with atherosclerotic disease. Recently, nuclear magnetic resonance (NMR)-based lipoprotein particles, low-density and high-density lipoprotein particles (LDL-p, HDL-p) in particular, have emerged as novel markers of atherosclerotic disease. It has been unclear, however, whether NMR-based particles are associated with AVC.
Purpose
To examine cross-sectional association of NMR-based lipoprotein particles, standard lipids with AVC, and compare their strengths of association.
Methods
We studied a community-based random sample of Japanese men aged 40–79 years examined in 2006–08 in Japan. We excluded participants with history of myocardial infarction, stroke, aortic valve surgery, serum triglyceride concentration ≥400 mg/dl, estimated glomerular filtration rate (eGFR) <30 (ml/min/1.73m2), and use of lipid-lowering medication. We scored the degree of AVC according to Agatston's method, and defined prevalent AVC as the score >0. Lipoprotein particles were measured using NMR spectroscopy.
In our main analysis, we obtained multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (95% CI) of prevalent AVC in the top quartile (Q4) for each lipid index in reference to the lowest quartile (Q1). Adjusting covariates include age, smoking, drinking, systolic blood pressure, glycated hemoglobin, medications for hypertension and/or for diabetes, eGFR, C-reactive protein. For sensitivity analysis, we repeated similar analyses presenting ORs per 1 standard deviation (SD) higher NMR-lipoproteins particles or standard lipids.
Results
Of 874 participants we analyzed, 153 (17.5%) men had AVC. The average (SD) age was 63.3 (10.0) years. Those with AVC tended to be older, likely to have clustering of atherosclerotic risk factors. Multivariable-adjusted ORs of prevalent AVC for Q4 versus Q1 were significantly positive for LDL-p [OR, 2.21 (95% CI: 1.24, 3.95] and low-density lipoprotein cholesterol (LDL-c) [2.17 (1.24, 3.80)]. In contrast, neither HDL-p nor high-density lipoprotein cholesterol (HDL-c) was significantly associated with AVC. In sensitivity analyses, however, the corresponding ORs per 1SD higher lipids/lipoprotein particles were smaller in LDL-p [1.33 (1.09, 1.63)] than LDL-c [1.41 (1.15, 1.73)]. The association of HDL-p became significant [1.28 (1.02, 1.61)] (per 1SD decrement) in the sensitivity analysis.
Conclusion
The overall associations of AVC with NMR-based lipoprotein particles (i.e. LDL-p, HDL-p) are comparable to those of standard lipids. This finding is parallel to the association between atherosclerotic cardiovascular diseases with NMR-based lipoproteins.
Collapse
Affiliation(s)
- T Vu
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia and Department of Cardiovascular surgery, Shiga, Japan
| | - A Fujiyoshi
- Wakayama Medical University, Department of Hygiene, School of Medicine, Wakayama, Japan
| | - T Hisamatsu
- Shimane University, Department of Environmental Medicine and Public Health, Faculty of Medicine, Izumo, Japan
| | - A Kadota
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia and Department of Public Health, Shiga, Japan
| | - M Zaid
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia and Department of Public Health, Shiga, Japan
| | - H Segawa
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Shiga, Japan
| | - K Kondo
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia and Department of Public Health, Shiga, Japan
| | - T Asai
- Shiga University of Medical Science, Department of Cardiovascular Surgery, Shiga, Japan
| | - K Miura
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia and Department of Public Health, Shiga, Japan
| | - H Ueshima
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia and Department of Public Health, Shiga, Japan
| |
Collapse
|
25
|
Yamauchi H, Kondo K, Tanaka S, Okuda N, Nakagawa H, Sakata K, Saitoh S, Okayama A, Yoshita K, Miura K, Chan Q, Masaki K, Elliott P, Stamler J, Ueshima H. P6234The relationship of alcohol consumption with risk factors of coronary heart disease and the intake of macro- and micro-nutrients in Japanese: the INTERLIPID study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Many studies have reported the J-shaped relationship between alcohol consumption and coronary heart disease (CHD) risk; therefore, light-drinkers is generally recognized to be associated with the lower risk of CHD. However, the mechanisms of lower risk for CHD in light-drinkers are still unclear. Alcohol drinking status is likely to be associated with not only CHD risk factors but also dietary intake. Nevertheless, few studies report these relationships in detail.
Purpose
The purpose of this study is to evaluate the relationships of alcohol drinking status with CHD classical risk factors and the intake of macro- and micro- nutrients in Japanese.
Methods
Study participants were 1,090 Japanese men and women aged 40–59 years from The INTERLIPID study excepted for 55 individuals who had missing data (n=26) and were past-drinkers (n=29). Alcohol consumption was assessed with two 7-day alcohol records, and average ethanol intake (per week) was calculated. Participants were classified into following 4 groups: non-drinkers (0g/week), light-drinkers (<100 g/week), moderate-drinkers (100–299 g/week), and heavy-drinkers (≥300 g/week). Serum LDL and HDL cholesterol, blood pressure (BP), the prevalence of hypertension and dyslipidemia, and smoking status were assessed as CHD risk factors. The intake of energy and macro- and micro-nutrients were evaluated from the four-timed in-depth 24-hr dietary recalls. Nutrient intake densities were calculated per total energy intake without alcohol. The analysis of variance and chi-squared test were used to evaluate the relations of alcohol status with CHD risk factors and nutrient intake.
Results
Serum HDL cholesterol levels increased and LDL cholesterol levels decreased with increasing alcohol consumption. Systolic and diastolic BP increased with increasing alcohol consumption. J-shaped relationships with alcohol consumption were observed for the proportion of current smoker, number of cigarettes, and the prevalence of hypertension; that is, light-drinkers was lowest among all groups. The prevalence of dyslipidemia was the highest in non-drinkers, and decreased with increasing alcohol consumption. In heavy-drinkers, total energy (kcal/day) was the highest, but energy intake without alcohol (kcal/day) was the lowest. For macronutrients, the intake of carbohydrate (%kcal) decreased, and the intakes of total and animal protein (%kcal) increased with increasing alcohol consumption. The intakes of total cholesterol (mg/1000kcal) and sodium (mg/1000kcal) increased, and total fiber (g/1000kcal) decreased with increasing alcohol consumption. These associations were similar in men and women.
Conclusions
Alcohol consumption was related with not only CHD classical risk factors but also the intake of macro- and micro-nutrients. Non-drinkers had a higher proportion of some CHD risk factors than light-drinkers. These results might influence on J-shaped relationship between alcohol consumption and CHD risk.
Acknowledgement/Funding
1: Ministry of Education, Science, Sports, and Culture of Japan, 2: National Institutes of Health, Bethesda, MD, USA
Collapse
Affiliation(s)
- H Yamauchi
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Shiga, Japan
| | - K Kondo
- Shiga University of Medical Science, Department of Public Health, Shiga, Japan
| | - S Tanaka
- Shiga University of Medical Science, Department of Medical Statistics, Shiga, Japan
| | - N Okuda
- University of Human Arts and Sciences, Department of Health and Nutrition, Saitama, Japan
| | - H Nakagawa
- Kanazawa Medical University, Department of Epidemiology and Public Health, Kanazawa, Japan
| | - K Sakata
- Iwate Medical University, Department of Hygiene and Preventive Medicine, Iwate, Japan
| | - S Saitoh
- Sapporo Medical University, School of Health Sciences, School of Medicine, Sapporo, Japan
| | - A Okayama
- Research Institute of Strategy for Prevention, Tokyo, Japan
| | - K Yoshita
- Osaka City University, Department of Food Science and Nutrition, Osaka, Japan
| | - K Miura
- Shiga University of Medical Science, Department of Public Health, Shiga, Japan
| | - Q Chan
- Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, London, United Kingdom
| | - K Masaki
- University of Hawaii and Kuakini Medical Center, Department of Geriatric Medicine, John A. Burns School of Medicine, Honolulu, United States of America
| | - P Elliott
- Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, London, United Kingdom
| | - J Stamler
- Northwestern University, Department of Preventive Medicine, Feinberg School of Medicine, Chicago, United States of America
| | - H Ueshima
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Shiga, Japan
| |
Collapse
|
26
|
Miura K, Harita Y, Tsurumi H, Takahashi K, Igarashi T, Iijima K, Hattori M. SUN-329 Clinical manifestations and genetic analysis of primary distal renal tubular acidosis. Kidney Int Rep 2019. [DOI: 10.1016/j.ekir.2019.05.738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
27
|
Miura K, Olsen C, Rea S, Marsden J, Green A. 飞行员和空乘人员的黑色素瘤和皮肤癌. Br J Dermatol 2019. [DOI: 10.1111/bjd.18072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
|
29
|
Kanno M, Miura K, Masaki Y, Tsujimura H, Iino M, Takizawa J, Maeda Y, Yamamoto K, Tamura S, Yoshida A, Yagi H, Yoshida I, Kitazume K, Masunari T, Choi I, Kakinoki Y, Suzuki R, Yoshino T, Nakamura S, Yoshida T. CONSOLIDATION THERAPY USING 90
Y-IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012). Hematol Oncol 2019. [DOI: 10.1002/hon.61_2631] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- M. Kanno
- Oncology Center; Nara Medical University Hospital; Kashihara Japan
| | - K. Miura
- Division of Hematology and Rheumatology; Nihon University School of Medicine; Tokyo Japan
| | - Y. Masaki
- Department of Hematology and Immunology; Kanazawa Medical University; Ishikawa Japan
| | - H. Tsujimura
- Division of Medical Oncology; Chiba Cancer Center; Chiba Japan
| | - M. Iino
- Department of Medical Oncology; Yamanashi Prefectural Central Hospital; Kofu Japan
| | - J. Takizawa
- Department of Hematology; Endocrinology and Metabolism, Niigata University Faculty of Medicine; Niigata Japan
| | - Y. Maeda
- Department of Hematology and Oncology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan
| | - K. Yamamoto
- Department of Hematology; Okayama City Hospital; Okayama Japan
| | - S. Tamura
- Department of Hematology/Oncology; Kinan Hospital; Tanabe Japan
| | - A. Yoshida
- Department of Hematology; Toyama Prefectural Central Hospital; Toyama Japan
| | - H. Yagi
- Department of Hematology and Oncology; Nara Prefecture General Medical Center; Nara Japan
| | - I. Yoshida
- Department of Hematologic Oncology; National Hospital Organization, Shikoku Cancer Center; Matsuyama Japan
| | - K. Kitazume
- Department of Hematology; Showa General Hospital; Kodaira Japan
| | - T. Masunari
- Department of Infectious Diseases; Chugoku Central Hospital; Fukuyama Japan
| | - I. Choi
- Department of Hematology; National Hospital Organization, Kyushu Cancer Center; Fukuoka Japan
| | - Y. Kakinoki
- Department of Hematology; Asahikawa City Hospital; Ashikawa Japan
| | - R. Suzuki
- Department of Oncology/Hematology, Innovative Cancer Center; Shimane University Hospital; Izumo Japan
| | - T. Yoshino
- Department of Pathology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan
| | - S. Nakamura
- Department of Pathology and Biological Response; Nagoya University Graduate School of Medicine; Nagoya Japan
| | - T. Yoshida
- Member; Society of Lymphoma Treatment in Japan (SoLT-J); Kanazawa Japan
| |
Collapse
|
30
|
Hisamatsu T, Miura K, Fujiyoshi A, Kunimura A, Ito T, Miyazawa I, Torii S, Shiino A, Nozaki K, Kanda H, Arima H, Ohkubo T, Ueshima H. Association between excessive supraventricular ectopy and subclinical cerebrovascular disease: a population-based study. Eur J Neurol 2019; 26:1219-1225. [PMID: 31002446 DOI: 10.1111/ene.13970] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2018] [Accepted: 04/15/2019] [Indexed: 12/22/2022]
Abstract
BACKGROUND AND PURPOSE The association between an increased supraventricular ectopic beat (SVEB) and subclinical cerebrovascular disease remains unclear. Given the emerging concept that an increased SVEB is a marker of atrial cardiomyopathy or atherosclerosis burden, we sought to determine whether excessive supraventricular ectopic activity (ESVEA) is associated with a higher burden of subclinical cerebrovascular disease in the middle-aged to older cohort with neither apparent stroke nor atrial fibrillation. METHODS We conducted a cross-sectional population-based study of 462 men (mean age, 68.1 years) who underwent 24-h Holter electrocardiography and brain magnetic resonance imaging. ESVEA was defined as the presence of >10 SVEBs/h. Subclinical cerebrovascular diseases were defined as silent brain infarct (SBI), white matter hyperintensity (WMH) and intracranial atherosclerotic stenosis (ICAS). The association of ESVEA with the presence of subclinical cerebrovascular diseases was adjusted for potential confounding covariates. RESULTS A total of 88 (19.0%) participants had ESVEA and 81 (17.5%), 91 (19.7%) and 109 (23.6%) had SBI, WMH and ICAS, respectively. In multivariable-adjusted Poisson regression with robust error variance, ESVEA was associated with the presence of WMH (relative risk, 1.58; 95% confidence interval, 1.06-2.36) and ICAS (relative risk, 1.49; 95% confidence interval, 1.02-2.18), but not with that of SBI (relative risk, 1.32; 95% confidence interval, 0.86-2.01). These associations were consistent when the graded distributions of subclinical cerebrovascular diseases were applied as outcomes in ordinal logistic regression. CONCLUSIONS The ESVEA was independently associated with higher burdens of WMH and ICAS. This suggests that increased SVEBs might improve risk stratification of individuals at high risk of subclinical cerebrovascular disease and consequently apparent ischaemic stroke.
Collapse
Affiliation(s)
- T Hisamatsu
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.,Department of Environmental Medicine and Public Health, Faculty of Medicine, Shimane University, Izumo, Japan.,Department of Public Health, Shiga University of Medical Science, Otsu, Japan
| | - K Miura
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan.,Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan
| | - A Fujiyoshi
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan
| | - A Kunimura
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan
| | - T Ito
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan
| | - I Miyazawa
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan
| | - S Torii
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan
| | - A Shiino
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan
| | - K Nozaki
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan.,Department of Neurosurgery, Shiga University of Medical Science, Otsu, Japan
| | - H Kanda
- Department of Environmental Medicine and Public Health, Faculty of Medicine, Shimane University, Izumo, Japan
| | - H Arima
- Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
| | - T Ohkubo
- Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan
| | - H Ueshima
- Department of Public Health, Shiga University of Medical Science, Otsu, Japan.,Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan
| | | |
Collapse
|
31
|
Miura K, Olsen C, Rea S, Marsden J, Green A. Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta‐analysis. Br J Dermatol 2019; 181:55-64. [DOI: 10.1111/bjd.17586] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/20/2018] [Indexed: 11/28/2022]
Affiliation(s)
- K. Miura
- Population Health Department QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia
| | - C.M. Olsen
- Population Health Department QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia
| | - S. Rea
- Population Health Department QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia
| | - J. Marsden
- Queen Elizabeth Hospital Birmingham B15 2GW U.K
| | - A.C. Green
- Population Health Department QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia
- CRUK Manchester Institute and Faculty of Biology, Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester U.K
| |
Collapse
|
32
|
Nawashiro Y, Shiraki K, Yamamoto S, Takizawa K, Sasada Y, Suehiro M, Miura K, Hattori M, Daikoku T, Hisano M. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report. Transplant Proc 2018; 50:3932-3936. [PMID: 30577289 DOI: 10.1016/j.transproceed.2018.09.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Accepted: 09/05/2018] [Indexed: 11/16/2022]
Abstract
BACKGROUND Cytomegalovirus (CMV) could cause rejection in immunocompromised patients during early post-renal transplant stage. The American Transplant Society guidelines recommend prophylactic therapy with ganciclovir (GCV) for 3 to 6 months to prevent CMV infections in adult renal transplant patients. However, there is no recommended CMV treatment regimen for pediatric patients. MAIN FINDINGS We performed deceased donor kidney transplant from an anti-CMV antibody-positive donor to an anti-CMV antibody-negative 15-year-old female recipient with end-stage renal disease caused by bilateral renal hypoplasia. One month after transplant, increase in positive cells in the CMV antigenemia assay indicated a primary CMV infection in the patient, who immediately received GCV. She was switched to foscarnet after 4 months of anti-CMV therapy because of clinical GCV resistance. CMV was isolated from the peripheral blood mononuclear cells but neutralizing antibody was not detected. Isolated CMV was susceptible to GCV and foscarnet, although it carried the UL97 D605E mutation, assumed to be associated with GCV resistance. CONCLUSIONS The primary CMV infection presented a phenotypic clinical drug resistance, but all recovered CMV isolates were drug-susceptible even if isolated after prolonged anti-CMV therapy, indicating that immune status was more important for recovery from primary CMV infection than anti-CMV therapy.
Collapse
Affiliation(s)
- Y Nawashiro
- Department of Nephrology, Chiba Children's Hospital, Chiba, Japan.
| | - K Shiraki
- Department of Virology, University of Toyama, Toyama, Japan
| | - S Yamamoto
- Department of Nephrology, Chiba Children's Hospital, Chiba, Japan
| | - K Takizawa
- Department of Nephrology, Chiba Children's Hospital, Chiba, Japan
| | - Y Sasada
- Department of Nephrology, Chiba Children's Hospital, Chiba, Japan
| | - M Suehiro
- Department of Nephrology, Chiba Children's Hospital, Chiba, Japan
| | - K Miura
- Department of Pediatric Nephrology, Tokyo Women's Medical University, Tokyo, Japan
| | - M Hattori
- Department of Pediatric Nephrology, Tokyo Women's Medical University, Tokyo, Japan
| | - T Daikoku
- Department of Life Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
| | - M Hisano
- Department of Nephrology, Chiba Children's Hospital, Chiba, Japan
| |
Collapse
|
33
|
Miura K, Higashijima A, Hasegawa Y, Miura S, Yoshida A, Masuzaki H. Decreased plasma concentrations of pregnancy-associated placenta-specific microRNAs in pregnancies with a diagnosis of fetal trisomy 18. CLIN EXP OBSTET GYN 2018. [DOI: 10.12891/ceog4355.2018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
34
|
Kobayashi T, Miura K, Ishikawa H, Soma D, Ando T, Yuza K, Hirose Y, Katada T, Takizawa K, Nagahashi M, Sakata J, Kameyama H, Wakai T. Long-term Follow-up of Laparoscope-Assisted Living Donor Hepatectomy. Transplant Proc 2018; 50:2597-2600. [DOI: 10.1016/j.transproceed.2018.03.035] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Accepted: 03/06/2018] [Indexed: 11/16/2022]
|
35
|
Kanno M, Miura K, Masaki Y, Tsujimura H, Iino M, Takizawa J, Maeda Y, Yamamoto K, Tamura S, Yoshida A, Yagi H, Yoshida I, Kitazume K, Masunari T, Choi I, Kakinoki Y, Yoshino T, Nakamura S, Yoshida T. Bendamustine and rituximab followed by 90Y-ibritumomab tiuxetan for relapsed follicular lymphoma: A preliminary analysis of a multicenter, prospective phase II study (BRiZ2012). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy286.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Sumitomo-Kondo M, Ukai Y, Iba Y, Ohshima N, Miura K, Takasaki A, Kurosawa Y, Kurosawa G. Isolation of human monoclonal antibodies that bind to two different antigens and are encoded by germline V H and V L genes. Biochem Biophys Res Commun 2018; 503:1141-1147. [PMID: 29944883 DOI: 10.1016/j.bbrc.2018.06.132] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2018] [Accepted: 06/23/2018] [Indexed: 10/28/2022]
Abstract
This paper reports isolation of two monoclonal antibodies (mAbs) that bind to both a membrane protein and a cytoplasmic protein. Most Abs established as markers for autoimmune disease bind to cytoplasmic or nuclear substances. However, it remains unknown how these Abs are produced. On the other hand, there were examples where clones originally isolated as Abs that bind to membrane proteins also showed binding activity to cytoplasmic or nuclear substances. Based on these results, the following hypothesis has been proposed. The Abs that had been originally produced against a membrane protein showed cross-reactivity against cytoplasmic or nuclear substances. In the present study we reported isolation of Abs that bound to both a membrane protein, CADM1, and a cytoplasmic protein, α-actinin-4. The method adopted in the present study could be generally applicable to isolation of Abs showing such dual specificity. Firstly, we constructed a huge human Ab library using various organs including naïve B-cell-rich organs such as bone marrow and umbilical cords. Then, we developed a comprehensive screening method for isolation of Abs that bound to cell surface antigens. Through extensive screenings with many kinds of cell we newly obtained a library composed of around 4000 independent clones that bind to membrane proteins. We screened this library with α-actinin-4 and succeeded in isolating two Abs. They bound to α-actinin-4 and a membrane protein CADM1. Furthermore, they are encoded by naïve heavy and light chain variable genes (VH & VL). These results suggested that cross-reactive Abs to both a membrane protein and a cytoplasmic protein could be present in germline repertoire of Ab in humans. This methodology adopted in the present study could be applied to isolation of cross-reactive Abs possibly involved in autoimmune diseases.
Collapse
Affiliation(s)
- M Sumitomo-Kondo
- Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan; Perseus Proteomics Inc., Tokyo, Japan
| | - Y Ukai
- Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan; Perseus Proteomics Inc., Tokyo, Japan
| | - Y Iba
- Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan
| | - N Ohshima
- Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan
| | - K Miura
- School of Health Sciences Fujita Health University, Toyoake, Japan
| | - A Takasaki
- Department of Medical Technology School of Health Sciences, Gifu University of Medical Science, Gifu, Japan
| | - Y Kurosawa
- Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan
| | - G Kurosawa
- Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan.
| |
Collapse
|
37
|
Murata M, Kondo J, Iwabuchi N, Takahashi S, Yamauchi K, Abe F, Miura K. Effects of paraprobiotic Lactobacillus paracasei MCC1849 supplementation on symptoms of the common cold and mood states in healthy adults. Benef Microbes 2018; 9:855-864. [PMID: 30099891 DOI: 10.3920/bm2017.0197] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
We investigated the effects of paraprobiotic Lactobacillus paracasei MCC1849 (LAC-Shield™) on symptoms of the common cold and mood states in healthy young adults. A total of 241 participants were randomised to receive 1×1010 heat-killed L. paracasei MCC1849 cell powder (10LP), 3×1010 heat-killed L. paracasei MCC1849 cell powder (30LP), or placebo powder without any L. paracasei cells once daily for 12 weeks based on the incidence of the common cold in the previous year, so that the risk of the incidence was equal among the groups. The incidence and severity of common cold symptoms were rated daily in a subject diary. Salivary secretory immunoglobulin A concentrations and saliva flow rates were analysed at 0 and 6 weeks. The Profile of Mood States (POMS) was assessed using POMS 2 0, 6, and 12 weeks after the intervention. No significant differences were observed in the incidence of the common cold among the groups. In a prespecified subgroup of subjects who had the common cold in the previous year, the incidence, total number of days of symptoms, and symptom scores of the common cold significantly improved in the 10LP-intake group, and were slightly lower in the 30LP-intake group than in the placebo group. The level of deterioration in the positive mood state caused by stress was less in the MCC1849-intake group than in the placebo group. These results indicate that L. paracasei MCC1849 has the potential to improve resistance to common cold infections in susceptible subjects and maintain a desirable mood state, even under mental stress conditions. Further randomised controlled trials are needed in order to investigate the possible beneficial effects of paraprobiotic L. paracasei MCC1849 on the common cold in susceptible populations.
Collapse
Affiliation(s)
- M Murata
- 1 Food Ingredients & Technology Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, 252-8583 Zama-city, Kanagawa, Japan
| | - J Kondo
- 2 Department of Food and Nutrition, Higashi Chikushi Junior College, 5-1-1, Shimoitouzu, Kokurakita-ku, 803-8511 Kitakyushu-city, Fukuoka, Japan
| | - N Iwabuchi
- 1 Food Ingredients & Technology Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, 252-8583 Zama-city, Kanagawa, Japan
| | - S Takahashi
- 1 Food Ingredients & Technology Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, 252-8583 Zama-city, Kanagawa, Japan
| | - K Yamauchi
- 1 Food Ingredients & Technology Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, 252-8583 Zama-city, Kanagawa, Japan
| | - F Abe
- 1 Food Ingredients & Technology Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, 252-8583 Zama-city, Kanagawa, Japan
| | - K Miura
- 3 Department of Nutrition, Faculty of Home Economics, Kyushu Women's University, 1-1-1, Jiyugaoka, Yahatanishi-ku, 807-8586 Kitakyushu-city, Fukuoka, Japan
| |
Collapse
|
38
|
Okamura T, Kakino A, Miura K, Fujiyoshi A, Kadota A, Fujita Y, Zaid M, Usami Y, Hisamastu T, Horiuchi S, Kunimura A, Sugiyama D, Kondo K, Sawamura T, Ueshima H. 51Serum modified high density lipoprotein levels assessed by a novel assay was associated with coronary artery calcification in an apparently healthy population. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.51] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- T Okamura
- Keio University School of Medicine, Preventive Medicine and Public Health, Tokyo, Japan
| | - A Kakino
- Shinshu University, Physiology, Matsumoto, Japan
| | - K Miura
- Shiga University of Medical Science, Otsu, Japan
| | - A Fujiyoshi
- Shiga University of Medical Science, Otsu, Japan
| | - A Kadota
- Shiga University of Medical Science, Otsu, Japan
| | - Y Fujita
- Shinshu University, Physiology, Matsumoto, Japan
| | - M Zaid
- Shiga University of Medical Science, Otsu, Japan
| | - Y Usami
- Shinshu University, Physiology, Matsumoto, Japan
| | - T Hisamastu
- Shimane University, Faculty of Medicine, Izumo, Japan
| | - S Horiuchi
- Shinshu University, Physiology, Matsumoto, Japan
| | - A Kunimura
- Shiga University of Medical Science, Otsu, Japan
| | - D Sugiyama
- Keio University School of Medicine, Preventive Medicine and Public Health, Tokyo, Japan
| | - K Kondo
- Shiga University of Medical Science, Otsu, Japan
| | - T Sawamura
- Shinshu University, Physiology, Matsumoto, Japan
| | - H Ueshima
- Shiga University of Medical Science, Otsu, Japan
| | | |
Collapse
|
39
|
Kadota A, Miura K, Fujiyoshi A, Hisamatsu T, Kadowaki S, Zaid M, Miyagawa N, Kondo K, Kunimura A, Okamura T, Ueshima H. P4448The association of coronary artery calcification progression, albuminuria and estimated glomerular filtration rate among general population. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Kadota
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Otsu, Japan
| | - K Miura
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Otsu, Japan
| | - A Fujiyoshi
- Shiga University of Medical Science, Department of Public Health, Otsu, Japan
| | - T Hisamatsu
- Shimane University, Dpeartment of Enviromental Medicine and Public Health, Izumo, Japan
| | - S Kadowaki
- Shiga University of Medical Science, Department of Public Health, Otsu, Japan
| | - M Zaid
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Otsu, Japan
| | - N Miyagawa
- Shiga University of Medical Science, Department of Public Health, Otsu, Japan
| | - K Kondo
- Shiga University of Medical Science, Department of Public Health, Otsu, Japan
| | - A Kunimura
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Otsu, Japan
| | - T Okamura
- Keio University School of Medicine, Department of Preventive Medicine and Public Health, Tokyo, Japan
| | - H Ueshima
- Shiga University of Medical Science, Center for Epidemiologic Research in Asia, Otsu, Japan
| | | |
Collapse
|
40
|
Amano H, Kadota K, Kuwayama A, Miura K, Ohya M, Shimada T, Kubo S, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T. P4560Long-term outcomes of iatrogenic coronary artery dissection during cardiac catheterization. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4560] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Amano
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Kurashiki, Japan
| | - A Kuwayama
- Kurashiki Central Hospital, Kurashiki, Japan
| | - K Miura
- Kurashiki Central Hospital, Kurashiki, Japan
| | - M Ohya
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Shimada
- Kurashiki Central Hospital, Kurashiki, Japan
| | - S Kubo
- Kurashiki Central Hospital, Kurashiki, Japan
| | - S Otsuru
- Kurashiki Central Hospital, Kurashiki, Japan
| | - S Habara
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Tada
- Kurashiki Central Hospital, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Kurashiki, Japan
| | - T Goto
- Kurashiki Central Hospital, Kurashiki, Japan
| |
Collapse
|
41
|
Ohya M, Kuwayama A, Miura K, Shimada T, Murai R, Amano H, Kubo S, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. P3673In-hospital bleeding and utility of a maintenance dose of prasugrel 2.5 mg in high bleeding risk patients with acute coronary syndrome. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Ohya
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - A Kuwayama
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - K Miura
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - T Shimada
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - R Murai
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - H Amano
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - S Kubo
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - S Otsuru
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - S Habara
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - T Tada
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - H Tanaka
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - Y Fuku
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - T Goto
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| | - K Kadota
- Kurashiki Central Hospital, Cardiology Department, Kurashiki, Japan
| |
Collapse
|
42
|
Borsanyi S, Fodor Z, Hoelbling C, Kawanai T, Krieg S, Lellouch L, Malak R, Miura K, Szabo KK, Torrero C, Toth BC. Hadronic Vacuum Polarization Contribution to the Anomalous Magnetic Moments of Leptons from First Principles. Phys Rev Lett 2018; 121:022002. [PMID: 30085700 DOI: 10.1103/physrevlett.121.022002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2017] [Indexed: 06/08/2023]
Abstract
We compute the leading, strong-interaction contribution to the anomalous magnetic moment of the electron, muon, and tau using lattice quantum chromodynamics (QCD) simulations. Calculations include the effects of u, d, s, and c quarks and are performed directly at the physical values of the quark masses and in volumes of linear extent larger than 6 fm. All connected and disconnected Wick contractions are calculated. Continuum limits are carried out using six lattice spacings. We obtain a_{e}^{LO-HVP}=189.3(2.6)(5.6)×10^{-14}, a_{μ}^{LO-HVP}=711.1(7.5)(17.4)×10^{-10} and a_{τ}^{LO-HVP}=341.0(0.8)(3.2)×10^{-8}, where the first error is statistical and the second is systematic.
Collapse
Affiliation(s)
- Sz Borsanyi
- Department of Physics, Bergische Universität Wuppertal, Gaussstrasse 20, D-42119 Wuppertal, Germany
| | - Z Fodor
- Department of Physics, Bergische Universität Wuppertal, Gaussstrasse 20, D-42119 Wuppertal, Germany
- Institute for Theoretical Physics, Eötvös University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary
- Jülich Supercomputing Centre, Forschungszentrum Jülich, D-52425 Jülich, Germany
| | - C Hoelbling
- Department of Physics, Bergische Universität Wuppertal, Gaussstrasse 20, D-42119 Wuppertal, Germany
| | - T Kawanai
- Jülich Supercomputing Centre, Forschungszentrum Jülich, D-52425 Jülich, Germany
| | - S Krieg
- Department of Physics, Bergische Universität Wuppertal, Gaussstrasse 20, D-42119 Wuppertal, Germany
- Jülich Supercomputing Centre, Forschungszentrum Jülich, D-52425 Jülich, Germany
| | - L Lellouch
- CNRS, Aix-Marseille Université, Université de Toulon, CPT, UMR 7332, F-13288 Marseille, France
| | - R Malak
- CNRS, Aix-Marseille Université, Université de Toulon, CPT, UMR 7332, F-13288 Marseille, France
- CNRS, CEA, Maison de la Simulation, USR 3441, F-91191 Gif-sur-Yvette Cedex, France
| | - K Miura
- CNRS, Aix-Marseille Université, Université de Toulon, CPT, UMR 7332, F-13288 Marseille, France
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, Nagoya University, Nagoya 464-8602, Japan
| | - K K Szabo
- Department of Physics, Bergische Universität Wuppertal, Gaussstrasse 20, D-42119 Wuppertal, Germany
- Jülich Supercomputing Centre, Forschungszentrum Jülich, D-52425 Jülich, Germany
| | - C Torrero
- CNRS, Aix-Marseille Université, Université de Toulon, CPT, UMR 7332, F-13288 Marseille, France
| | - B C Toth
- Department of Physics, Bergische Universität Wuppertal, Gaussstrasse 20, D-42119 Wuppertal, Germany
| |
Collapse
|
43
|
Tsukinoki R, Murakami Y, Miura K, Okamura T, Kadota A, Hayakawa T, Okayama A, Ueshima H. The relationship between healthy life expectancy and smoking, hypertension and body mass index in a Japanese population: A multistate life table method using Nippon Data90. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
44
|
Murakami Y, Tsukinoki R, Miura K, Okamura T, Kadota A, Okayama A, Ueshima H. Comparison of methods for calculating healthy life expectancy in a Japanese population: An analysis of Nippon Data90. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
45
|
Namiki T, Nojima K, Hashimoto T, Hanafusa T, Tokoro S, Miura K, Tanaka M, Yokozeki H. Borst-Jadassohn phenomenon arising from a seborrhoeic keratosis and its characteristic dermoscopic features. Clin Exp Dermatol 2018; 43:940-941. [PMID: 29888802 DOI: 10.1111/ced.13653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/25/2017] [Indexed: 11/30/2022]
Affiliation(s)
- T Namiki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - K Nojima
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - T Hashimoto
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - T Hanafusa
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - S Tokoro
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - K Miura
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - M Tanaka
- Department of Dermatology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
| | - H Yokozeki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| |
Collapse
|
46
|
Sone Y, Namiki T, Tokoro S, Miura K, Yokozeki H. A case of neutrophilic dermatoses including pyoderma gangrenosum as a continuous disease spectrum to SAPHO syndrome. Clin Exp Dermatol 2018; 43:829-831. [PMID: 29756300 DOI: 10.1111/ced.13620] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/13/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Y Sone
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - T Namiki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - S Tokoro
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - K Miura
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - H Yokozeki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| |
Collapse
|
47
|
Fushimi C, Tada Y, Takahashi H, Nagao T, Ojiri H, Masubuchi T, Matsuki T, Miura K, Kawakita D, Hirai H, Hoshino E, Kamata S, Saotome T. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 2018; 29:979-984. [PMID: 29211833 PMCID: PMC5913639 DOI: 10.1093/annonc/mdx771] [Citation(s) in RCA: 96] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Background There is no standard first-line chemotherapy for recurrent/metastatic (RM) or unresectable locally advanced (LA) salivary gland carcinoma (SGC). Patients and methods We conducted a single institution, open-label, single arm, phase II trial of combined androgen blockade (CAB) for androgen receptor (AR)-positive SGC. Leuprorelin acetate was administered subcutaneously at a dose of 3.75 mg every 4 weeks. Bicalutamide was administered orally at a daily dose of 80 mg. Patients were treated until progressive disease or unacceptable toxicities. Results Thirty-six eligible patients were enrolled. Thirty-three patients had RM disease and three patients had LA disease. The pathological diagnoses were salivary duct carcinoma (34 patients, 94%) and adenocarcinoma, NOS (two patients, 6%). The best overall response rate was 41.7% [n = 15, 95% confidence interval (CI), 25.5%-59.2%], the clinical benefit rate was 75.0% (n = 27, 95% CI, 57.8%-87.9%). The median progression-free survival was 8.8 months (95% CI, 6.3-12.3 months) and the median overall survival was 30.5 months (95% CI, 16.8 months to not reached). Additional analyses between treatment outcomes and clinicopathological factors or biomarkers including AR positivity, human epidermal growth factor receptor 2 status, and its complex downstream signaling pathway gene mutations showed no statistically significant differences. Elevated grade 3 liver transaminases and increased serum creatinine were reported in two patients, respectively. Discontinuation of leuprorelin acetate or bicalutamide due to adverse event occurred in one patient. Conclusion This study suggests that CAB has equivalent efficacy and less toxicity for patients with AR-positive RM or unresectable LA SGC compared with conventional chemotherapy, which warrants further study. Clinical Trial Registration UMIN-CTR (http://www.umin.ac.jp/ctr/index-j.htm), identification number: UMIN000005703.
Collapse
Affiliation(s)
- C Fushimi
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
| | - Y Tada
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
| | - H Takahashi
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
| | - T Nagao
- Department of Anatomic Pathology, Tokyo Medical University School of Medicine, Tokyo, Japan
| | - H Ojiri
- Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan
| | - T Masubuchi
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
| | - T Matsuki
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
| | - K Miura
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
| | - D Kawakita
- Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - H Hirai
- Department of Anatomic Pathology, Tokyo Medical University School of Medicine, Tokyo, Japan
| | - E Hoshino
- Support Unit for Conducting Clinically Essential Studies, Graduate School of Public Health, St Luke's International University, Tokyo, Japan
| | - S Kamata
- Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
| | - T Saotome
- Division of Medical Oncology, Matsudo City Hospital, Chiba, Japan
| |
Collapse
|
48
|
Hiroshima Y, Fukumitsu N, Ishida T, Nakamura M, Shimizu S, Sekino Y, Miyauchi D, Iizumi T, Miura K, Kanuma R, Tanaka K, Saito T, Takizawa D, Numajiri H, Onishi K, Mizumoto M, Aihara T, Ishikawa H, Okumura T, Tsuboi K, Sakurai H. PO-0770: Concurrent chemoradiotherapy using photon and proton for locally advanced pancreatic cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31080-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
49
|
Miura K, Miyakawa S, Narayama S, Hirano H, Kanai K, Miwa T. Athletes as Health Testing Examinees. Methods Inf Med 2018. [DOI: 10.1055/s-0038-1634913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Abstract:Health-testing examination data of 91 male and 54 female athletes were studied, together with age-matched controls, on serum biochemistry, ECG findings, hematology, and some data on gynecological physiology. Analysis of serum biochemical values revealed statistically significant differences in 14 of 18 routine test items as compared with the age-matched controls. In ECG findings, the combination of bradycardia and left ventricular hypertrophy was most frequently found in male athletes, whereas that of bradycardia and sinus arrythmia was observed predominantly in female athletes. The incidence of anemia and menstrual dysfunction was higher in female athletes than in controls, especially in the basketball team. In the same team, a high rate of deviant ECG records and a different distribution of the age at menarche were also observed.
Collapse
|
50
|
Takagi K, Miura K, Nakanuma S, Sakamoto S, Yamamoto H, Yagi T, Eguchi S, Ohta T, Wakai T, Ohtsuka M, Uemoto S, Kasahara M, Inomata Y. Six National University Consortium in Liver Transplant Professionals Training (SNUC-LT) Program in Japan. Transplant Proc 2018; 50:168-174. [DOI: 10.1016/j.transproceed.2017.11.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2017] [Revised: 10/09/2017] [Accepted: 11/03/2017] [Indexed: 10/18/2022]
|